Trudi buys TBI 27.78: Neuralstem Final Phase I Depression Data Presented At The American Society Of Clinical Psychopharmacology Annual Meeting
June 18, 2014 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that final data from ... Additional indications might include traumatic brain injury (TBI), Alzheimer's disease, and post-traumatic stress disorder (PTSD). For more information ... ...
41 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home